Engagement of the Pd-1 Immunoinhibitory Receptor by a Novel B7 Family Member Leads to Negative Regulation of Lymphocyte ActivationGordon J. Freeman, Tasuku Honjo, Heidi F. Horton et al.|The Journal of Experimental Medicine|2000Cited by 5.2k
PD-L2 is a second ligand for PD-1 and inhibits T cell activationYvette Latchman, Gordon J. Freeman, Clive R. Wood et al.|Nature Immunology|2001Cited by 2.9k
ICOS is critical for CD40-mediated antibody class switchingAlexander J. McAdam, Arlene H. Sharpe, Rebecca J. Greenwald et al.|Nature|2001Cited by 644
The Role of B7‐1/B7‐2:CD28/CLTA‐4 Pathways in the Prevention of Anergy, Induction of Productive Immunity and Down‐Regulation of the Immune ResponseVassiliki A. Boussiotis, L M Nadler, Gordon J. Freeman et al.|Immunological Reviews|1996Cited by 161
Both CD28 ligands CD80 (B7-1) and CD86 (B7-2) activate phosphatidylinositol 3-kinase, and wortmannin reveals heterogeneity in the regulation of T cell IL-2 secretionYuji Ueda, Stephen G. Ward, Bruce L. Levine et al.|International Immunology|1995Cited by 74